Establishment Labs Holdings Inc. Research and Development Expense
Establishment Labs Holdings Inc. (ESTA) reported Research and Development Expense of $5.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- Establishment Labs Holdings Inc. research and development expense for the quarter ending 2026-06-30 was $5.10M, a 2.06% decline year-over-year.
- Establishment Labs Holdings Inc. research and development expense for the quarter ending 2026-03-31 was $5.24M, a 3.68% increase year-over-year.
- Establishment Labs Holdings Inc. research and development expense for the quarter ending 2025-12-31 was $5.43M, a 5.64% increase year-over-year.
- Establishment Labs Holdings Inc. research and development expense for the quarter ending 2025-09-30 was $4.55M, a 5.12% decline year-over-year.
- Establishment Labs Holdings Inc. research and development expense for fiscal 2025 was $20.25M, a 2.75% increase from fiscal 2024.
- Establishment Labs Holdings Inc. research and development expense for fiscal 2024 was $19.71M, a 25.44% decline from fiscal 2023.
- Establishment Labs Holdings Inc. research and development expense for fiscal 2023 was $26.43M, a 30.39% increase from fiscal 2022.
- Establishment Labs Holdings Inc. research and development expense for fiscal 2022 was $20.27M, a 10.67% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.10M 10-Q · filed 2026-08-07 | $10.34M 10-Q · filed 2026-08-07 | $15.77M derived: sum of 3 quarters · filed 2026-08-07 | $20.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $5.24M 10-Q · filed 2026-05-08 | $10.68M derived: sum of 2 quarters · filed 2026-05-08 | $15.23M derived: sum of 3 quarters · filed 2026-05-08 | $20.43M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.99M derived: sum of 2 quarters · filed 2026-02-27 | $15.19M derived: sum of 3 quarters · filed 2026-08-07 | $20.25M 10-K · filed 2026-02-27 |
| 2025-09-30 | $4.55M 10-Q · filed 2025-11-07 | $9.76M derived: sum of 2 quarters · filed 2026-08-07 | $14.81M 10-Q · filed 2025-11-07 | $19.96M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $5.20M 10-Q · filed 2026-08-07 | $10.26M 10-Q · filed 2026-08-07 | $15.40M derived: sum of 3 quarters · filed 2026-08-07 | $20.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $5.05M 10-Q · filed 2026-05-08 | $10.20M derived: sum of 2 quarters · filed 2026-05-08 | $15.00M derived: sum of 3 quarters · filed 2026-05-08 | $20.49M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.95M derived: sum of 2 quarters · filed 2026-02-27 | $15.43M derived: sum of 3 quarters · filed 2026-02-27 | $19.71M 10-K · filed 2026-02-27 |
| 2024-09-30 | $4.80M 10-Q · filed 2025-11-07 | $10.29M derived: sum of 2 quarters · filed 2025-11-07 | $14.56M 10-Q · filed 2025-11-07 | $20.38M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $5.49M 10-Q · filed 2025-08-07 | $9.76M 10-Q · filed 2025-08-07 | $15.58M derived: sum of 3 quarters · filed 2026-02-27 | $22.71M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $4.27M 10-Q · filed 2025-05-09 | $10.09M derived: sum of 2 quarters · filed 2026-02-27 | $17.22M derived: sum of 3 quarters · filed 2026-02-27 | $24.17M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $12.95M derived: sum of 2 quarters · filed 2026-02-27 | $19.89M derived: sum of 3 quarters · filed 2026-02-27 | $26.43M 10-K · filed 2026-02-27 |
| 2023-09-30 | $7.13M 10-Q · filed 2024-11-12 | $14.07M derived: sum of 2 quarters · filed 2024-11-12 | $20.61M 10-Q · filed 2024-11-12 | $27.09M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $6.95M 10-Q · filed 2024-08-07 | $13.48M 10-Q · filed 2024-08-07 | $19.96M derived: sum of 3 quarters · filed 2025-02-28 | $25.25M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $6.53M 10-Q · filed 2024-05-09 | $13.01M derived: sum of 2 quarters · filed 2025-02-28 | $18.30M derived: sum of 3 quarters · filed 2025-02-28 | $23.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.77M derived: sum of 2 quarters · filed 2025-02-28 | $16.67M derived: sum of 3 quarters · filed 2025-02-28 | $20.27M 10-K · filed 2025-02-28 |
| 2022-09-30 | $5.29M 10-Q · filed 2023-11-08 | $10.19M derived: sum of 2 quarters · filed 2023-11-08 | $13.79M 10-Q · filed 2023-11-08 | $19.82M derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-06-30 | $4.90M 10-Q · filed 2023-08-09 | $8.50M 10-Q · filed 2023-08-09 | $14.54M derived: sum of 3 quarters · filed 2024-03-04 | $18.42M derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-03-31 | $3.60M 10-Q · filed 2023-05-10 | $9.63M derived: sum of 2 quarters · filed 2024-03-04 | $13.52M derived: sum of 3 quarters · filed 2024-03-04 | $17.86M derived: sum of 4 quarters · filed 2024-03-04 |
| 2021-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $9.92M derived: sum of 2 quarters · filed 2024-03-04 | $14.27M derived: sum of 3 quarters · filed 2024-03-04 | $18.32M 10-K · filed 2024-03-04 |
| 2021-09-30 | $3.88M 10-Q · filed 2022-11-09 | $8.23M derived: sum of 2 quarters · filed 2022-11-09 | $12.28M 10-Q · filed 2022-11-09 | $16.75M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $4.35M 10-Q · filed 2022-08-09 | $8.40M 10-Q · filed 2022-08-09 | $12.86M derived: sum of 3 quarters · filed 2023-03-01 | $15.59M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $4.05M 10-Q · filed 2022-05-10 | $8.51M derived: sum of 2 quarters · filed 2023-03-01 | $11.24M derived: sum of 3 quarters · filed 2023-03-01 | $13.64M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $7.20M derived: sum of 2 quarters · filed 2023-03-01 | $9.59M derived: sum of 3 quarters · filed 2023-03-01 | $13.79M 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.73M 10-Q · filed 2021-11-09 | $5.13M derived: sum of 2 quarters · filed 2021-11-09 | $9.33M 10-Q · filed 2021-11-09 | $12.96M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.40M 10-Q · filed 2021-07-30 | $6.60M 10-Q · filed 2021-07-30 | $10.23M derived: sum of 3 quarters · filed 2022-03-01 | $14.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $4.20M 10-Q · filed 2021-05-06 | $7.83M derived: sum of 2 quarters · filed 2022-03-01 | $11.61M derived: sum of 3 quarters · filed 2022-03-01 | $15.61M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.41M derived: sum of 2 quarters · filed 2022-03-01 | $11.41M derived: sum of 3 quarters · filed 2022-03-01 | $14.99M 10-K · filed 2022-03-01 |
| 2019-09-30 | $3.78M 10-Q · filed 2020-11-09 | $7.78M derived: sum of 2 quarters · filed 2020-11-09 | $11.36M 10-Q · filed 2020-11-09 | $15.02M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $4.00M 10-Q · filed 2020-08-07 | $7.58M 10-Q · filed 2020-08-07 | $11.25M derived: sum of 3 quarters · filed 2020-08-07 | $14.42M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $3.58M 10-Q · filed 2020-05-08 | $7.25M derived: sum of 2 quarters · filed 2020-05-08 | $10.42M derived: sum of 3 quarters · filed 2020-05-08 | $14.12M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $6.83M derived: sum of 2 quarters · filed 2020-03-16 | $10.54M derived: sum of 3 quarters · filed 2020-03-16 | $12.69M 10-K · filed 2020-03-16 |
| 2018-09-30 | $3.17M 10-Q · filed 2019-11-12 | $6.88M derived: sum of 2 quarters · filed 2019-11-12 | $9.03M 10-Q · filed 2019-11-12 | $11.47M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $3.71M 10-Q · filed 2019-08-13 | $5.85M 10-Q · filed 2019-08-13 | $8.30M derived: sum of 3 quarters · filed 2019-08-13 | $9.73M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $2.15M 10-Q · filed 2019-05-15 | $4.59M derived: sum of 2 quarters · filed 2019-05-15 | $6.03M derived: sum of 3 quarters · filed 2019-05-15 | $7.51M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $3.88M derived: sum of 2 quarters · filed 2019-03-20 | $5.36M derived: sum of 3 quarters · filed 2019-03-20 | $6.86M 10-K · filed 2019-03-20 |
| 2017-09-30 | $1.44M 10-Q · filed 2018-11-13 | $2.92M derived: sum of 2 quarters · filed 2018-11-13 | $4.42M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $1.48M 10-Q · filed 2018-09-13 | $2.98M 10-Q · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |